- #UPPER CHEST DISCOMFORT NSAID HOW TO#
- #UPPER CHEST DISCOMFORT NSAID SKIN#
- #UPPER CHEST DISCOMFORT NSAID FULL#
- #UPPER CHEST DISCOMFORT NSAID PROFESSIONAL#
If you previously had Guillain-Barré syndrome (temporary loss of feeling and movement) or transverse myelitis (inflammation of the spinal cord) after being given COVID-19 Vaccine AstraZeneca. #UPPER CHEST DISCOMFORT NSAID FULL#
If you are immunocompromised and receive a third dose of COVID-19 Vaccine AstraZeneca, it may still not provide full immunity to COVID-19 and you should continue to maintain physical precautions to help prevent COVID-19.
If your immune system does not work properly (immunodeficiency) or you are taking medicines that weaken the immune system (such as high-dose corticosteroids, immunosuppressants or cancer medicines). If you have a problem with bleeding or bruising, or if you are taking a blood thinning medicine (anticoagulant). If you have ever had a condition known as heparin-induced thrombocytopenia and thrombosis (HITT or HIT type 2), or a blood clot in the sinus veins in the brain. However, a mild fever or infection, like a cold, are not reasons to delay vaccination. 
If you currently have a severe infection with a high temperature (over 38☌). If you have ever fainted following any needle injection. #UPPER CHEST DISCOMFORT NSAID PROFESSIONAL#
Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency room right away if you have an allergic reaction.
#UPPER CHEST DISCOMFORT NSAID SKIN#
Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. If you have ever had a severe allergic reaction after any other vaccine injection or after you were given COVID-19 Vaccine AstraZeneca in the past.Tell your doctor, pharmacist or nurse before vaccination: If you are not sure, talk to your doctor, pharmacist or nurse. If you have a previous diagnosis of capillary leak syndrome (a condition causing fluid leakage from small blood vessels).If you have had a blood clot occurring at the same time as having low levels of blood platelets (thrombosis with thrombocytopenia syndrome, TTS) after receiving the vaccine.If you are allergic to any of the active substances or any of the other ingredients listed in section 6.What you need to know before you are given COVID-19 Vaccine AstraZeneca None of the ingredients in this vaccine can cause COVID-19. This will help to protect you against COVID-19 in the future. It causes the body to produce its own protection (antibodies) against the virus. What COVID-19 Vaccine AstraZeneca is and what it is used forĬOVID-19 Vaccine AstraZeneca is a vaccine used for preventing COVID 19, caused by a virus called coronavirus (SARS-CoV-2).ĬOVID-19 Vaccine AstraZeneca is given to adults aged 18 years and older.ĬOVID-19 Vaccine AstraZeneca stimulates the body’s natural defences (immune system). Contents of the pack and other informationġ.
#UPPER CHEST DISCOMFORT NSAID HOW TO#
How to store COVID-19 Vaccine AstraZeneca. How COVID-19 Vaccine AstraZeneca is given. 
What you need to know before you are given COVID-19 Vaccine AstraZeneca. What COVID-19 Vaccine AstraZeneca is and what it is used for. This includes any possible side effects not listed in this leaflet. If you get any side effects, talk to your doctor, pharmacist or nurse. If you have any further questions, ask your doctor, pharmacist or nurse. Read all of this leaflet carefully before the vaccine is given because it contains important information for you. See the end of section 4 for how to report side effects. You can help by reporting any side effects you may get. Reporting of side effectsĪs with any new medicine in the UK this product will be closely monitored to allow quick identification of new safety information. It does not have a marketing authorisation, but this temporary authorisation grants permission for the medicine to be used for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19). This medicinal product has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency. Regulation 174 Information for UK recipients Package leaflet: Information for the recipientĬOVID-19 Vaccine AstraZeneca solution for injectionĬOVID-19 Vaccine (ChAdOx1 S )
0 kommentar(er)
